Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Genes & Nutrition

Fig. 2

From: Quercetin supplementation in metabolic syndrome: nutrigenetic interactions with the Zbtb16 gene variant in rodent models

Fig. 2

Effect of quercetin supplementation on blood glucose levels during oral glucose tolerance test (A), area under the curve (AUC, B) and insulin (C) levels. Values are mean ± SEM, n = 5/6 for each group; SHR and SHR-Zbtb16; control rats, SHR-Q and SHR-Zbtb16-Q; rats supplemented with quercetin; post-hoc Fisher’s least significant difference test of the two-way ANOVA for STRAIN and Q as major factors are indicated as follows: α represents differences in SHR-Q vs. SHR-Zbtb16-Q rats, χ represents differences in SHR vs. SHR-Q rats, β represents differences in SHR vs. SHR-Zbtb16 rats, α, significantly different compared to SHR-Q; β, significantly different compared to SHR-Zbzt16; χ, significantly different compared to SHR-Zbtb16-Q. SHR and SHR-Zbtb16; control rats, SHR-Q and SHR-Zbtb16-Q; rats supplemented with quercetin

Back to article page